By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced the completion of its acquisition of Accuri Cytometers for an undisclosed amount.

Based in Ann Arbor, Mich., Accuri develops personal flow cytometers. The acquisition, announced last month during BD's first quarter earnings release, helps expand the use of flow cytometry technology in regions where ease of use and affordability are critical, BD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.